FinnCap reiterated their corporate rating on shares of Innovaderma (LON:IDP) in a research report released on Wednesday morning.
Shares of Innovaderma opened at GBX 148.50 ($1.92) on Wednesday, according to MarketBeat Ratings. Innovaderma has a 52-week low of GBX 117 ($1.51) and a 52-week high of GBX 410.50 ($5.31).
InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in Europe, the United States, Australasia, Asia, and Africa. It offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee name; and tailored solutions under the Leimo name for hair loss comprising shampoos, conditioners, and laser technology treatments developed to combat male and female hair loss, alopecia, thinning hair.
Further Reading: Dividend
Receive News & Ratings for Innovaderma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovaderma and related companies with MarketBeat.com's FREE daily email newsletter.